Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111321176A reveals a lipase-catalyzed route for high-purity 4-octyl itaconate, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN114318375B reveals a green electrochemical route to Indolo[2,3-a]carbazole. High purity, scalable production for OLED and electronic chemical manufacturing.
Patent CN101586032B details ionic liquid catalysis for P-S flame retardants. Achieve superior char formation and supply chain efficiency with scalable manufacturing.
Patent CN1817841A reveals ionic liquid catalysis for unsaturated ketones. Enhances purity and supply chain reliability for fragrance and pharma intermediates.
Patent CN104311484A reveals efficient ionic liquid catalysis for quinoline derivatives, offering significant supply chain and cost advantages for pharmaceutical intermediates manufacturing.
Patent CN104558029A reveals a high-yield synthesis route for bis(dicyclohexylphosphine)alkane ligands, offering significant cost reduction and supply chain reliability for industrial manufacturing.
Patent CN105543201B details a mutant enzyme boosting 7-ACA yield. Discover cost reduction in API manufacturing and reliable pharmaceutical intermediates supplier solutions.
Novel 7-MAC synthesis from 7-ACA avoids diazo hazards. High purity pharmaceutical intermediate supply with reduced environmental impact.
Patent CN115536681A reveals a novel Ir-catalyzed method for selective para-borylation of anisoles. Discover cost-effective supply chain solutions for high-purity pharmaceutical intermediates.
Patent CN105968068B reveals a mild nickel-catalyzed cyclization method offering significant cost reduction and supply chain reliability for high-purity heterocyclic intermediates.
Patent CN107163014B reveals a novel lanthanide-catalyzed route for icariine. Achieve high purity and scalable manufacturing with our advanced pharmaceutical intermediates supply chain solutions.
Novel 3-step route for Pregabalin avoids resolution waste. High ee value up to 99.6%. Cost-effective manufacturing for pharma intermediates.
Patent CN117343075A reveals a novel organocatalytic route for high-purity chiral spirocyclic intermediates, offering significant supply chain stability and cost advantages.
Novel patent CN101195622A offers safer famciclovir synthesis. Reduces hazardous reagents and improves scalability for pharmaceutical intermediate supply chains.
Patent CN104370956A reveals efficient Antioxidant 168 synthesis. Achieve high purity and yield for polymer stability. Reliable supply chain solutions available.
Patent CN1235954A details a liquid-phase isomerization of alpha-isophorone to beta-isophorone using alkali salts, offering high selectivity and industrial scalability for vitamin E precursors.
Patent CN111944774B reveals novel MLADH enzyme for high-purity (R)-PED production. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN117049973A details a green visible light method for aromatic amine functionalization, offering cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN102286000A reveals an enzymatic route for cefonicid. Achieve higher purity and reduced corrosion in antibiotic manufacturing with scalable solutions.
Patent CN103215238B details novel marine esterase PE8 for high-purity pharmaceutical intermediates. Enables cost reduction in API intermediate manufacturing with scalable enzymatic hydrolysis.